Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bloch

Showing results (321-330 of 559) with videos related to

Pageof 56
Sort By:
American Journal of Human Genetics|October 23, 1997
Risk reversals in predictive testing for Huntington diseaseE Almqvist, S Adam, M Bloch, et al.
Transfusion|September 3, 2023
How do we ensure a safe ABO recheck process?Laura D Stephens, Elizabeth S Allen, Evan M Bloch, et al.
Transfusion|October 17, 2024
It is time to reconsider leukoreduction of whole blood for use in patients with life-threatening hemorrhageMark H Yazer, Andrew Beckett, Evan M Bloch, et al.
Mutation Research|January 27, 1999
Trinucleotide repeat length variation in the human ribosomal protein L14 gene (RPL14): localization to 3p21.3 and loss of heterozygosity in lung and oral cancersS P Shriver, M D Shriver, D L Tirpak, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|November 15, 2024
Trends in new hepatitis C virus infections among repeat blood donors - Georgia, 2017-2023Shaun Shadaker, Davit Baliashvili, Maia Alkhazashvili, et al.
American Journal of Medical Genetics|February 15, 1992
Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased riskM Huggins, M Bloch, S Wiggins, et al.
Journal of Medical Genetics|July 1, 1993
Five year study of prenatal testing for Huntington's disease: demand, attitudes, and psychological assessmentS Adam, S Wiggins, P Whyte, et al.
Journal of Clinical Apheresis|February 19, 2026
When Strong Recommendations Rest on Weak Evidence: Lessons From Therapeutic Apheresis GuidelinesJeremy W Jacobs, Garrett S Booth, Brian D Adkins, et al.
Journal of Virology|June 1, 1994
Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicityB D Jamieson, G M Aldrovandi, V Planelles, et al.
Archives of Toxicology|February 15, 2021
Assessment of the impact of mitochondrial genotype upon drug-induced mitochondrial dysfunction in platelets derived from healthy volunteersAmy L Ball, Katarzyna M Bloch, Lucille Rainbow, et al.
Pageof 56

Showing results (321-330 of 559) with videos related to

Sort By:
Pageof 56
American Journal of Human Genetics|October 23, 1997
Risk reversals in predictive testing for Huntington diseaseE Almqvist, S Adam, M Bloch, et al.
Transfusion|September 3, 2023
How do we ensure a safe ABO recheck process?Laura D Stephens, Elizabeth S Allen, Evan M Bloch, et al.
Transfusion|October 17, 2024
It is time to reconsider leukoreduction of whole blood for use in patients with life-threatening hemorrhageMark H Yazer, Andrew Beckett, Evan M Bloch, et al.
Mutation Research|January 27, 1999
Trinucleotide repeat length variation in the human ribosomal protein L14 gene (RPL14): localization to 3p21.3 and loss of heterozygosity in lung and oral cancersS P Shriver, M D Shriver, D L Tirpak, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|November 15, 2024
Trends in new hepatitis C virus infections among repeat blood donors - Georgia, 2017-2023Shaun Shadaker, Davit Baliashvili, Maia Alkhazashvili, et al.
American Journal of Medical Genetics|February 15, 1992
Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased riskM Huggins, M Bloch, S Wiggins, et al.
Journal of Medical Genetics|July 1, 1993
Five year study of prenatal testing for Huntington's disease: demand, attitudes, and psychological assessmentS Adam, S Wiggins, P Whyte, et al.
Journal of Clinical Apheresis|February 19, 2026
When Strong Recommendations Rest on Weak Evidence: Lessons From Therapeutic Apheresis GuidelinesJeremy W Jacobs, Garrett S Booth, Brian D Adkins, et al.
Journal of Virology|June 1, 1994
Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicityB D Jamieson, G M Aldrovandi, V Planelles, et al.
Archives of Toxicology|February 15, 2021
Assessment of the impact of mitochondrial genotype upon drug-induced mitochondrial dysfunction in platelets derived from healthy volunteersAmy L Ball, Katarzyna M Bloch, Lucille Rainbow, et al.
Pageof 56